Fabio A B Schutz

Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study.

Michael B Atkins, P. Kantoff, S. Signoretti, 2013, The Lancet. Oncology.

Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials.

T. Choueiri, F. Schutz, Fabio A B Schutz, 2009, The Lancet. Oncology.

Comparison of four early posttherapy imaging changes (EPTIC; RECIST 1.0, tumor shrinkage, computed tomography tumor density, Choi criteria) in assessing outcome to vascular endothelial growth factor-targeted therapy in patients with advanced renal cell carcinoma.

Ivan Pedrosa, A. D. Van den Abbeele, Annick D Van den Abbeele, 2011, European Urology.

Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine.

Joaquim Bellmunt, T. Choueiri, J. Rosenberg, 2012, European journal of cancer.